SCHEMBL7079565

SCHEMBL7079565

CCCCCc1cc(O)c(N)c(=O)o1

nearest known ligand 0.72

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ELANE P08246 5/20 0.59
MAPT P10636 2/20 0.49
ALOX15 P16050 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.40
STS P08842 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TP53 P04637 1/20 0.40
GAA P10253 1/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 1/20 0.40
SRC P12931 1/20 0.40
TLR8 Q9NR97 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.39
ALOX5 P09917 1/20 0.38
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7081099 0.98 ELANE (0.58) ELANEMAPTALOX15SMN1; SMN2STS
SCHEMBL8780178 0.84 ELANE (0.63) ELANEMAPTALOX15SMN1; SMN2HTT
Pseudopyronines B SCHEMBL17867169 0.84 ELANE (0.63) ELANEMAPTALOX15SMN1; SMN2HTT
SCHEMBL2819257 0.84 ELANE (0.63) ELANEMAPTALOX15SMN1; SMN2HTT
SCHEMBL8780172 0.79 ELANE (0.62) ELANEMAPTALOX15SMN1; SMN2SRC
SCHEMBL7402457 0.78 ELANE (0.56) ELANEMAPTALOX15SMN1; SMN2SRC
SCHEMBL10338016 0.76 ELANE (0.97) ELANEMAPTALOX15ALDH1A1HTT
SCHEMBL7078053 0.76 ELANE (0.58) ELANEMAPTALOX15SMN1; SMN2ALDH1A1
SCHEMBL7132434 0.76 ELANE (0.54) ELANEMAPTALOX15SMN1; SMN2ALDH1A1
SCHEMBL10337743 0.76 ELANE (0.92) ELANEMAPTALOX15ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed